| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918727 | Radiotherapy and Oncology | 2013 | 7 Pages |
Abstract
OAR movement is difficult to predict though significant changes occur in individual patients. In 61% of cases in our sample the D2cc dose changed by at least 10% for at least one OAR from that planned. Pre-treatment imaging with subsequent adjustment of dosimetry will minimise the impact of organ movement on delivered dose.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Clare Anderson, Gerry Lowe, Rachel Wills, David Inchley, Victoria Beenstock, Linda Bryant, Caroline Chapman, Peter J. Hoskin,